“Long-Term Safety, Tolerability, and Efficacy of Vismodegib in Two Patients With Metastatic Basal Cell Carcinoma and Basal Cell Nevus Syndrome”. 2011. Dermatology Reports 3 (3): e55. https://doi.org/10.4081/dr.2011.e55.